TY - JOUR
T1 - An International, Mixed-Methods Study of the Perceived Intrusiveness of Remote Digital Diabetes Monitoring
AU - Oikonomidi, Theodora
AU - Ravaud, Philippe
AU - James, Arthur
AU - Cosson, Emmanuel
AU - Montori, Victor
AU - Tran, Viet Thi
N1 - Funding Information:
Conflicts of Interest: Theodora Oikonomidi received a fellowship from the doctoral network of the Ecole des Hautes Etudes en Santé Publique (EHESP, Rennes, France). No other conflicts of interest are reported. No specific funding has been received for this research.
Funding Information:
The authors thank Elise Diard for developing the study website and designing the figures, Gabriel Baron for consulting on the statistical analysis plan, and Laura Smales for editing the manuscript; the doctoral network of the Ecole des Hautes Etudes en Sant? Publique (EHESP), the study participants, and the organizations that disseminated the study (listed in Appendix 1). Conflicts of Interest: Theodora Oikonomidi received a fellowship from the doctoral network of the Ecole des Hautes Etudes en Sant? Publique (EHESP, Rennes, France). No other conflicts of interest are reported. No specific funding has been received for this research. Grant Support: Theodora Oikonomidi received a fellowship from the doctoral network of the EHESP (Rennes, France).
Publisher Copyright:
© 2020 Mayo Foundation for Medical Education and Research
PY - 2021/5
Y1 - 2021/5
N2 - Objective: To assess the relationship between remote digital monitoring (RDM) modalities for diabetes and intrusiveness in patients’ lives. Patients and Methods: Online vignette-based survey (February 1 through July 1, 2019). Adults with diabetes (type 1, 2, or subtypes such as latent autoimmune diabetes of adulthood) assessed three randomly selected vignettes among 36 that combined different modalities for monitoring tools (three options: glucose- and physical activity [PA]–monitoring only, or glucose- and PA-monitoring with occasional or regular food monitoring), duration/feedback loops (six options: monitoring for a week before all vs before specific consultations with feedback given in consultation, vs monitoring permanently, with real-time feedback by one's physician vs by anoter caregiver, vs monitoring permanently, with real-time, artificial intelligence-generated treatment feedback vs treatment and lifestyle feedback), and data handling (two options: by the public vs private sector). We compared intrusiveness (assessed on a 5-point scale) across vignettes and used linear mixed models to identify intrusiveness determinants. We collected qualitative data to identify aspects that drove participants’ perception of intrusiveness. Results: Overall, 1010 participants from 30 countries provided 2860 vignette-assessments (52% were type 1 diabetes). The monitoring modalities associated with increased intrusiveness were food monitoring compared with glucose- and PA-monitoring alone (β=0.34; 95% CI, 0.26 to 0.42; P<.001) and permanent monitoring with real-time physician-generated feedback compared with monitoring for a week with feedback in consultation (β=0.25; 95% CI, 0.16 to 0.34, P<.001). Public-sector data handling was associated with decreased intrusiveness as compared with private-sector (β=−0.15; 95% CI, −0.22 to −0.09; P<.001). Four drivers of intrusiveness emerged from the qualitative analysis: practical/psychosocial burden (eg, RDM attracting attention in public), control, data safety/misuse, and dehumanization of care. Conclusion: RDM is intrusive when it includes food monitoring, real-time human feedback, and private-sector data handling.
AB - Objective: To assess the relationship between remote digital monitoring (RDM) modalities for diabetes and intrusiveness in patients’ lives. Patients and Methods: Online vignette-based survey (February 1 through July 1, 2019). Adults with diabetes (type 1, 2, or subtypes such as latent autoimmune diabetes of adulthood) assessed three randomly selected vignettes among 36 that combined different modalities for monitoring tools (three options: glucose- and physical activity [PA]–monitoring only, or glucose- and PA-monitoring with occasional or regular food monitoring), duration/feedback loops (six options: monitoring for a week before all vs before specific consultations with feedback given in consultation, vs monitoring permanently, with real-time feedback by one's physician vs by anoter caregiver, vs monitoring permanently, with real-time, artificial intelligence-generated treatment feedback vs treatment and lifestyle feedback), and data handling (two options: by the public vs private sector). We compared intrusiveness (assessed on a 5-point scale) across vignettes and used linear mixed models to identify intrusiveness determinants. We collected qualitative data to identify aspects that drove participants’ perception of intrusiveness. Results: Overall, 1010 participants from 30 countries provided 2860 vignette-assessments (52% were type 1 diabetes). The monitoring modalities associated with increased intrusiveness were food monitoring compared with glucose- and PA-monitoring alone (β=0.34; 95% CI, 0.26 to 0.42; P<.001) and permanent monitoring with real-time physician-generated feedback compared with monitoring for a week with feedback in consultation (β=0.25; 95% CI, 0.16 to 0.34, P<.001). Public-sector data handling was associated with decreased intrusiveness as compared with private-sector (β=−0.15; 95% CI, −0.22 to −0.09; P<.001). Four drivers of intrusiveness emerged from the qualitative analysis: practical/psychosocial burden (eg, RDM attracting attention in public), control, data safety/misuse, and dehumanization of care. Conclusion: RDM is intrusive when it includes food monitoring, real-time human feedback, and private-sector data handling.
UR - http://www.scopus.com/inward/record.url?scp=85100654780&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85100654780&partnerID=8YFLogxK
U2 - 10.1016/j.mayocp.2020.07.040
DO - 10.1016/j.mayocp.2020.07.040
M3 - Article
C2 - 33487438
AN - SCOPUS:85100654780
SN - 0025-6196
VL - 96
SP - 1236
EP - 1247
JO - Mayo Clinic Proceedings
JF - Mayo Clinic Proceedings
IS - 5
ER -